vs

Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.

Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $83.1M, roughly 1.7× PROCEPT BioRobotics Corp). Purple Innovation, Inc. runs the higher net margin — -2.3% vs -38.1%, a 35.8% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 9.1%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 8.3%).

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”

PRCT vs PRPL — Head-to-Head

Bigger by revenue
PRPL
PRPL
1.7× larger
PRPL
$140.7M
$83.1M
PRCT
Growing faster (revenue YoY)
PRCT
PRCT
+11.1% gap
PRCT
20.2%
9.1%
PRPL
Higher net margin
PRPL
PRPL
35.8% more per $
PRPL
-2.3%
-38.1%
PRCT
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
8.3%
PRPL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
PRCT
PRCT
PRPL
PRPL
Revenue
$83.1M
$140.7M
Net Profit
$-31.6M
$-3.2M
Gross Margin
64.9%
41.9%
Operating Margin
-4.1%
-1.6%
Net Margin
-38.1%
-2.3%
Revenue YoY
20.2%
9.1%
Net Profit YoY
-27.9%
62.1%
EPS (diluted)
$-0.56
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRCT
PRCT
PRPL
PRPL
Q1 26
$83.1M
Q4 25
$76.4M
$140.7M
Q3 25
$83.3M
$118.8M
Q2 25
$79.2M
$105.1M
Q1 25
$69.2M
$104.2M
Q4 24
$68.2M
$129.0M
Q3 24
$58.4M
$118.6M
Q2 24
$53.4M
$120.3M
Net Profit
PRCT
PRCT
PRPL
PRPL
Q1 26
$-31.6M
Q4 25
$-29.8M
$-3.2M
Q3 25
$-21.4M
$-11.7M
Q2 25
$-19.6M
$-17.3M
Q1 25
$-24.7M
$-19.1M
Q4 24
$-18.9M
$-8.5M
Q3 24
$-21.0M
$-39.2M
Q2 24
$-25.6M
$27.0K
Gross Margin
PRCT
PRCT
PRPL
PRPL
Q1 26
64.9%
Q4 25
60.6%
41.9%
Q3 25
64.8%
42.8%
Q2 25
65.4%
35.9%
Q1 25
63.9%
39.4%
Q4 24
64.0%
42.9%
Q3 24
63.2%
29.7%
Q2 24
59.0%
40.7%
Operating Margin
PRCT
PRCT
PRPL
PRPL
Q1 26
-4.1%
Q4 25
-40.6%
-1.6%
Q3 25
-27.8%
-10.2%
Q2 25
-28.0%
-13.5%
Q1 25
-39.7%
-13.9%
Q4 24
-28.9%
-6.0%
Q3 24
-38.4%
-39.5%
Q2 24
-50.3%
-12.1%
Net Margin
PRCT
PRCT
PRPL
PRPL
Q1 26
-38.1%
Q4 25
-39.1%
-2.3%
Q3 25
-25.7%
-9.9%
Q2 25
-24.7%
-16.5%
Q1 25
-35.8%
-18.4%
Q4 24
-27.6%
-6.6%
Q3 24
-35.9%
-33.1%
Q2 24
-48.0%
0.0%
EPS (diluted)
PRCT
PRCT
PRPL
PRPL
Q1 26
$-0.56
Q4 25
$-0.54
$0.03
Q3 25
$-0.38
$0.11
Q2 25
$-0.35
$0.16
Q1 25
$-0.45
$0.18
Q4 24
$-0.34
$0.08
Q3 24
$-0.40
$0.36
Q2 24
$-0.50
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRCT
PRCT
PRPL
PRPL
Cash + ST InvestmentsLiquidity on hand
$245.6M
$24.3M
Total DebtLower is stronger
$51.7M
$126.7M
Stockholders' EquityBook value
$347.7M
$-29.7M
Total Assets
$487.1M
$296.3M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRCT
PRCT
PRPL
PRPL
Q1 26
$245.6M
Q4 25
$286.5M
$24.3M
Q3 25
$294.3M
$32.4M
Q2 25
$302.7M
$34.2M
Q1 25
$316.2M
$21.6M
Q4 24
$333.7M
$29.0M
Q3 24
$196.8M
$23.4M
Q2 24
$214.1M
$23.4M
Total Debt
PRCT
PRCT
PRPL
PRPL
Q1 26
$51.7M
Q4 25
$51.6M
$126.7M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
$70.7M
Q3 24
$51.4M
$50.8M
Q2 24
$51.4M
Stockholders' Equity
PRCT
PRCT
PRPL
PRPL
Q1 26
$347.7M
Q4 25
$365.9M
$-29.7M
Q3 25
$380.3M
$-26.9M
Q2 25
$385.8M
$-15.6M
Q1 25
$389.2M
$1.3M
Q4 24
$402.2M
$20.2M
Q3 24
$241.2M
$28.0M
Q2 24
$251.8M
$66.4M
Total Assets
PRCT
PRCT
PRPL
PRPL
Q1 26
$487.1M
Q4 25
$508.1M
$296.3M
Q3 25
$511.5M
$302.1M
Q2 25
$513.1M
$303.8M
Q1 25
$519.4M
$293.8M
Q4 24
$534.0M
$307.8M
Q3 24
$374.1M
$309.3M
Q2 24
$374.4M
$362.1M
Debt / Equity
PRCT
PRCT
PRPL
PRPL
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
3.50×
Q3 24
0.21×
1.82×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRCT
PRCT
PRPL
PRPL
Operating Cash FlowLast quarter
$-5.8M
Free Cash FlowOCF − Capex
$-7.8M
FCF MarginFCF / Revenue
-5.5%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRCT
PRCT
PRPL
PRPL
Q1 26
Q4 25
$-10.3M
$-5.8M
Q3 25
$-6.6M
$-968.0K
Q2 25
$-15.0M
$-4.0M
Q1 25
$-17.0M
$-23.1M
Q4 24
$-32.4M
$6.8M
Q3 24
$-18.8M
$1.1M
Q2 24
$-15.7M
$-8.9M
Free Cash Flow
PRCT
PRCT
PRPL
PRPL
Q1 26
Q4 25
$-12.2M
$-7.8M
Q3 25
$-9.5M
$-1.8M
Q2 25
$-17.8M
$-7.0M
Q1 25
$-18.8M
$-25.3M
Q4 24
$-33.6M
$5.7M
Q3 24
$-19.0M
$101.0K
Q2 24
$-16.8M
$-11.0M
FCF Margin
PRCT
PRCT
PRPL
PRPL
Q1 26
Q4 25
-15.9%
-5.5%
Q3 25
-11.4%
-1.5%
Q2 25
-22.5%
-6.6%
Q1 25
-27.2%
-24.3%
Q4 24
-49.2%
4.4%
Q3 24
-32.6%
0.1%
Q2 24
-31.4%
-9.2%
Capex Intensity
PRCT
PRCT
PRPL
PRPL
Q1 26
Q4 25
2.4%
1.4%
Q3 25
3.4%
0.7%
Q2 25
3.5%
2.8%
Q1 25
2.7%
2.2%
Q4 24
1.7%
0.8%
Q3 24
0.4%
0.9%
Q2 24
2.0%
1.7%
Cash Conversion
PRCT
PRCT
PRPL
PRPL
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-330.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

PRPL
PRPL

Cost Of Revenues$81.7M58%
Other$59.0M42%

Related Comparisons